← FDA DRUG APPROVALS

FDA ANDA · ANDA077198

ALPRAZOLAM

Sponsor: ACTAVIS LABS FL INC

APPLICATION
ANDA077198
TYPE
ANDA
ORIGINAL APPROVAL
2010-05-13
LATEST ACTION
2010-05-13
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ALPRAZOLAMDiscontinued
ALPRAZOLAM 3MG · TABLET, EXTENDED RELEASE · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 1MG · TABLET, EXTENDED RELEASE · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 2MG · TABLET, EXTENDED RELEASE · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.5MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2010-05-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →